Not a very nice topic but It could be very realistic. Just wanted to know If anyone had any ideas on which BIO companys and others could benefit from this if indeed we get the blessed germ in this Country.

Acambis and Biotrace perhaphs???????????????????????.

Whats Your thoughts?????????????????????????

cheers GF.

Never thought of that you negative genious. Who would then , virtually every one.?.

cheers Gf.

Yep :-)

Night mate.

Cheers Dil. Back on track any ideas on Bios?.

cheers GF.

Chemists and tissue manufacturers. Linen providers. Blimey Im gettting warped here. Its Dils fault.

Back to BIOS, any ideas.

cheers GF.

Hi GF,
The drug used in the treatment is called tarniflu, but I can't find out who manufactures it, as they would be the obvious beneficiaries.
Alan

Just another thought. Isolation is the only effect way to deal with this, in hospital. This is a labour intensive way to be treated by an NHS that is short of nurses anyway, so perhaps a PLC that deals in temp-nurse supply would also do well. They probably do anyway during the winter months, so it may be a good short term play if one exists.
Alan

PRB Pharmaceuticals in Hong Kong appear to be the leaders in developing effective measures against bird flu, but I don't think they are listed.
Alan

Well, if it gets as bad as some say then it could be good news for listed funeral directors:

dignity plc?

Bird incinerators manufactures would definitely benefit.

What about bernard Matthews and His Chicken Drummers. For chicken lovers everywhere, its prbably the only product you can get garaunteed not to contain any chicken. BOOTIFUL

Gravediggers would benifit.

Tarniflue is made by Roche I believe Hewitt.

Thanks Dil.

http://www.theage.com.au/news/BUSINESS/Roche-Glaxo-face-fights-over-flu-drugs/2005/10/14/1128796674898.html

mentions the Swiss Roche and US-based Gilead Sciences - responsible for Tamiflu (oseltamivir phosphate) - orally taken.
and Glaxo and Australian Biota - responsible for Relenza (zanamivir) - inhaled.

Biota's details on the ASX (have been in it since Aus$0.75 - tis now Aus$2.22);
http://www.asx.com.au/asx/research/CompanyInfoSearchResults.jsp?searchBy=asxCode&allinfo=&asxCode=bta
Was a speculative plunge for me - I had only got into it due to an article mentioning a favorable conclusion to Biota's court case against Glaxo; could potentially add up to a couple of $$ to the sp (which at the time was somewhere in the 50c range).


I understand that a lot of governmental stockpiling of Tamiflu (first), and then Relenza has been occurring. Both are for flu, but tis unkown (i think) as to whether it would be good enough to in fact combat the bird flu.......
CSL and Imugene (Australia), are also working on bird flu vaccine, but it all seems to have a long timeline to production - although i think that CSL are working with a UN health organisation in order to fasttrack something.

NOt sure about the UK and US listed companies......

Alan, is the drug you refer to not actually called Tamiflu which is indeed made by Roche as Dil points out.

http://www.rocheusa.com/products/tamiflu/

http://www.tamiflu.com/

Roche shares are traded on the Swiss exchange.

http://www.roche.com/home/investors/inv_share.htm

Tamiflu & Relenza are the only flu treatments that have some cover for the (H5N1 strain (BIRD FLU)) on the market at about 60 per course per person.
If you can get any, as every supplier I have tried has sold out.
this virus is still in birds and has not yet gone human to human, when and if it dose the strain must change slightly, then these treatments may not work !

Maybe Energy Tech. (ETQ) They could do with something to help them. If avian flu is an airborne pathogen (realise the absurdity of that!) ie once it has left a bird, then ETQ's suvair nightingale AC equipment would help considerably. Currently ETQ are a disaster area although now 50% underpinned by a subsid. of Tchenquiz family, so probably not the basket case that they would otherwise be. Don't expect to see any PR from the company promoting their products - their PR cons. are rubbish/non-existant!!

Indian drugmaker to make generic version of Tamiflu - report
AFX


LONDON (AFX) - Indian pharmaceutical manufacturer Cipla plans to produce a generic version of the anti-viral drug Tamiflu to counter a feared bird flu pandemic, the Financial Times reported quoting a company official.

'The whole world needs it and there is a tremendous shortage,' Cipla's joint managing director Amar Lulla told the paper, brushing off the potential threat of legal action from Tamiflu's maker Roche.

'We will sell it in many countries where there are no patents,' notably in Africa, the Middle East, Latin America and Asia,' Lulla said. 'We are not going into markets where there are valid patients,' such as Europe and the United States.

Cipla would sell its own version of oseltamivir, the generic name for Tamiflu, at a 'humanitarian' price below that of the Roche product, Lulla said, though he declined to give a figure.

Cipla, India's third largest drugs producer, also makes cheap generic versions of drugs to combat the AIDS virus.

I looked this up earlier, this would seem most up to date, can anyone tell me where the company is listed, the company is called "Sanofi pasteur"


http://www.newscientist.com/article.ns?id=dn8009&feedId=online-news_rss20

sanofi pasteur is a subsiduary of the parent company sanofi-aventis, listed on the Euronext (code ISIN FR0000120578) and NYSE (EPIC SNY)